China's Latest Cybersecurity Proposal Could Heighten Scrutiny On Device, Drug Industries

Medtech and biopharma are among key information infrastructure industries likely subject to additional security and reporting obligations under draft legislation, adding costs and even potentially causing business disruptions, legal experts say.